Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from NYSE

Myovant, Accord Healthcare Ink Relugolix Distribution Pact For Europe In Prostate Cancer

Myovant Sciences Ltd (NYSE:MYOV) and Accord Healthcare Ltd have entered into an exclusive license agreement to commercialize Orgovyx (relugolix) for advanced hormone-sensitive prostate cancer in the European Economic Area, the U.K., Switzerland, and Turkey. Accord has the right to the first negotiation if Myovant decides to enter into licensing arrangements in countries in the Middle…

Clarivate: Q1 Earnings Insights

Clarivate: Q1 Earnings Insights

Clarivate (NYSE:CLVT) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Recap: GCP Applied Technologies Q1 Earnings

Recap: GCP Applied Technologies Q1 Earnings

GCP Applied Technologies (NYSE:GCP) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

10 Biggest Price Target Changes For Monday

Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.

Why Party City Holdco Shares Are Trading Lower Today

Party City Holdco Inc (NYSE:PRTY) reported first-quarter FY22 sales growth of 1.4% year-on-year to $432.98 million, missing the consensus of $435.80 million. Brand comparable sales increased 2.1% versus last year. Total retail sales increased 2.3%. The gross profit margin decreased 380 basis points Y/Y to 31.9%. The operating loss for the quarter was…

The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More

Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ: IBB), considered a proxy for the sector, shed close to 3 percent during the week.

Morning Brief: Top Financial Stories Dominating on Monday, May 9

CNBC Ford Motor Selling 8M Shares Of Rivian Automotive

inkl

Read news from The Economist, FT, and more,
with one subscription

Experts Say These 2 Stocks Are Undervalued

Experts Say These 2 Stocks Are Undervalued

On CNBC's "The Final Call," Carter Worth said, “Gold is money. Everything else is credit.” He recommended JPMorgan Chase & Co (NYSE: JPM).

Uber CEO Calls For Cost Cutting, Treating Hiring As Privilege Amid Seismic Market Shift: Report

Uber CEO Calls For Cost Cutting, Treating Hiring As Privilege Amid Seismic Market Shift: Report

Uber Technologies Inc (NYSE: UBER) will cut costs to turn into a leaner business model to address a “seismic shift” in investor sentiment, CNBC reported o

Veritiv: Q1 Earnings Insights

Veritiv: Q1 Earnings Insights

Veritiv (NYSE:VRTV) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Emerald Holding Q1 Results Reveal 'Robust Recovery', Plans More Acquisitions Similar To MJBiz

Emerald Holding Q1 Results Reveal 'Robust Recovery', Plans More Acquisitions Similar To MJBiz

New York-headquartered B2B event and media company Emerald Holding, Inc. (NYSE: EEX) reported Monday financial results for the first quarter ended March 31, 2022.

Jim Cramer Shares His Thoughts On Chubb, Novavax And More

Jim Cramer Shares His Thoughts On Chubb, Novavax And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes the long-term prospects of Plug Power Inc (NASDAQ: PLUG). "Right now, this is a very tough day for a stock like Plug Power," he added.

BioNTech Clocks Over $6B In Q1 Sales, Sticks To FY22 Guidance

BioNTech Clocks Over $6B In Q1 Sales, Sticks To FY22 Guidance

BioNTech SE (NASDAQ:BNTX) has reported Q1 FY22 revenues of €6.37 billion compared to €2.05 billion a year ago, mainly due to high demand for the company's COVID-19 vaccine. In Q1 FY22, BioNTech and its partner Pfizer Inc (NYSE:PFE) have invoiced approximately 750 million COVID-19 vaccine doses. As of end-April 2022, the companies have signed orders…

AT&T, Comcast, Verizon, Others Join Government's Low-Income Broadband Plan

AT&T, Comcast, Verizon, Others Join Government's Low-Income Broadband Plan

Twenty internet providers agreed to help offer high-speed internet to millions of unconnected households through the bipartisan infrastructure law, the Wall Street Journal reports. The companies included AT&T Inc (NYSE:T), Comcast Corporation (NASDAQ: CMCSA), Verizon Communications Inc (NYSE: VZ), Cox Communications Inc, Charter Communications, Inc (NASDAQ: CHTR), Frontier Communications Parent, Inc (NASDAQ: FYBR) and regional providers like Jackson Energy Authority in Tennessee, Comporium Inc. in…

Get all your
news in one place.

100's of premium titles.
One news app.

CNBC's Final Trades: Lumen Technologies, US Dollar, Cinemark Holdings And This Energy Stock

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said, “Even with the market going green, I’m not too trusting of the market being a lot better for a long time.”

WideOpenWest: Q1 Earnings Insights

WideOpenWest (NYSE:WOW) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Palantir Technologies: Q1 Earnings Insights

Palantir Technologies (NYSE:PLTR) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

What Experts Make Of Crypto Crash, Musk Fears For Life, Payments Are Apple's Next Regulatory Battleground And More: 5 Key Stories You May Have Missed From This Weekend

The Federal Reserve's 50-basis-point interest rate hike announced last week triggered a positive reaction initially.

Get all your
news in one place.

100's of premium titles.
One news app.

Defense Companies Experience Supply Issues As Demand For US Weaponry Surges: FT

Northrop Grumman Corporation (NYSE: NOC) CEO Kathy Warden gave both good and bad news: the aerospace company anticipates increased demand for its weapons systems, but supply chain issues may hinder efforts to increase output,

A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street

Pre-open movers

Benzinga Bulls And Bears Of The Week: Disney, Apple, NVIDIA, Tesla And Why Meta Is Blaming Apple For User Loss

Benzinga has examined the prospects for many investor favorite stocks over the past week, while offering a 24/7 news feed, live chat and charting software on Benzinga Pro.

Here Is How Elon Musk Aims To Quintuple Twitter's Revenue By 2028

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk has assured Twitter Inc (NYSE: TWTR) investors that he could increase the company's revenue by many folds within a couple of years.

Lawsuit May Delay Elon Musk's Twitter Takeover: Here's What You Need To Know

A Florida-based pension fund is challenging Tesla Inc (NASDAQ: TSLA) CEO Elon Musk's potential $44 billion Twitter Inc (NYSE: TWTR) takeover.

EV Week In Review: Tesla Has Good News On Shanghai, Nio's Plans Amid Delisting Risk, And This Auto Giant Renews EV Leadership Pledge

Electric vehicle and allied sector stocks extended their losses in the week ending May 6, caught in the vortex of the broader market sell-off seen in the final two sessions of the week. Chinese EV stocks led the week's retreat amid fears that they could be potentially delisted from U.S. exchanges.

This is What Elon Musk Plans to Accomplish With Twitter If He Takes The Platform Private

Elon Musk took the world by surprise when he announced his intention to buy Twitter, Inc. (NYSE: TWTR).

1 … 277 278 279 280

People

Dara Khosrowshahi

Jenny Harrington

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Prostate Cancer

Places

361,281 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play